Skip to main content

Advertisement

Table 1 Adherence to NICE and local VTE pharmacological prophylaxis guidelines (all specialties combined)

From: Thromboprophylaxis prescribing among junior doctors: the impact of educational interventions

Parameter measured (N) Number of patients included
Pre-pro-forma (N = 124) Post- pro-forma (N = 77) Post- changeover of doctors (N = 98) Post-teaching (N = 95)
Indication(s) for pharmacological prophylaxis present, % (number) y = 94.4 % (117)
n = 5.6 %(7)
y = 88.3 % (68)
n = 10.4 % (8)
y = 92.9 % (91)
n = 6.1 % (6)
y = 93.7 % (89)
n = 6.3 % (6)
Contraindication(s) to pharmacological prophylaxis present, % (number) y = 10.5 % (13)
n = 87.9 % (109)
u/n = 1.6 % (2)
y = 19.5 % (15)
n = 80.5 %(62)
y = 13.3 % (13)
n = 81.8 % (81)
u/n = 4.9 % (4)
y = 26.3 % (25)
n = 73.7 % (70)
Documentation of risk assessment, % (number) y = 21.8 % (27)
n = 75.8 % (94)
u/n = 2.4 % (3)
y = 42.9 % (33)
n = 53.2 % (41)
u/n = 3.9 % (3)
y = 42.9 % (42)
n = 49.0 % (48)
u/n = 8.1 % (8)
y = 35.8 % (34)
n = 61.1 % (58)
u/n = 3.1 % (3)
Information regarding prophylaxis given to patient, % (number) y = 46 % (57)
n = 35.5 % (44)
u/n = 18.5 % (23)
y = 41.6 % (32)
n = 40.3 % (31)
u/n = 18.2 % (14)
y = 32.7 % (32)
n = 34.7 % (34)
u/n = 32.7 % (32)
y = 45.3 % (43) n = 24.2 % (23) u/n = 30.5 % (29)
Patients prescribed pharmacological prophylaxis, % (number) y = 72.6 % (90)
n = 25.8 % (32)
u/n = 1.6 % (2)
y = 74 % (57)
n = 23.4 % (18)
u/n = 2.6 % (2)
y = 61.2 % (60)
n = 35.7 % (35)
u/n = 3.1 % (3)
y = 62.1 % (59)
n = 36.8 % (35)
u/n = 1.1 % (1)
Patients prescribed pharmacological prophylaxis, where indication(s) present and contraindication(s) absent, % (number) Y = 80.6 % (83)
n = 18.4 % (19)
u/n = 1 %(1)
y = 92.9 % (52)
n = 3.6 % (2)
u/n = 3.6 %(2)
y = 75.7 % (56)
n = 21.6 % (16)
u/n = 2.7 % (2)
y = 78.5 % (51)
n = 20 % (13)
u/n = 1.5 % (1)
Patients prescribed pharmacological prophylaxis where contraindication(s) present, % (number) y = 30.8 % (4)
n = 69.2 % (9)
y = 20 % (3)
n = 80 % (12)
y = 7.7 % (1)
n = 92.3 % (12)
y = 32 % (8)
n = 68 % (17)
Adherence to prescribed pharmacological prophylaxis, (signed as given) % (number) y = 94.4 % (85)
n = 1.1 % (1)
u/n = 4.4 % (4)
y = 94.3 % (50)
n = 5.7 % (3)
u/n = 7 % (4)
y = 95 % (57)
n = 2.0 % (1)
u/n = 3.3 % (2)
y = 98.3 % (58)
n = 1.7 % (1)
Correct dose of pharmacological prophylaxis prescribed, % (number) y = 93.3 % (70)
n = 6.7 % (5)
u/n = 16.7 % (15)
y = 93 % (53)
n = 7 % (4)
y = 93.3 % (56)
n = 6.7 % (4)
y = 96.6 % (57)
n = 3.4 % (2)
How soon after admission pharmacological prophylaxis prescribed, % (number) <24 h = 82.2 % (74) >24 h = 13.3 % (15) u/n = 1.1 % (1) <24 h = 91.2 % (52) >24 h = 8.8 % (5) <24 h = 96.7 % (58) >24 h = 3.3 % (2) <24 h = 91.5 % (54) >24 h = 6.7 % (4) u/n = 1.7(1)
Type of pharmacological prophylaxis prescribed, % (number) Enoxaparin = 99.2 % (89) Unfractionated heparin = 0.8 (1) Enoxaparin=
100 % (57)
Enoxaparin = 98.3 % (59) Unfractionated heparin = 1.7(1) Enoxaparin = 100 % (59)
  1. This table shows prescribing-related data for all patients prior to and following interventions amongst all specialties combined. The rows relate to the prescribing of pharmacological thromboprophylaxis, including indication, dose and timing and whether anti-coagulation was indicated or contra-indicated. The three rows highlighted in bold text relate to: 1. The documentation of an assessment of risk, 2. The provision of information to patients and 3. Whether a patient was appropriately prescribed anti-coagulation when indicated and not contra-indicated. These highlighted rows represent key measures of compliance related to NICE guidelines. The third highlighted row relates to the proportion of appropriate pharmacological thromboprophylaxis prescribing where there is an indication and an absence of known contraindications and is calculated from the prescribing data captured in the rows above
  2. Key: y yes, n no, u/n unknown